Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,037
Total Claims
$1.7M
Drug Cost
918
Beneficiaries
$1,865
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-46%
Opioid rate vs peers
1.4% vs 2.6% avg
+75%
Cost per patient vs peers
$1,865 vs $1,068 avg
+42%
Brand preference vs peers
12.8% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.4%
Opioid Rate
169
Opioid Claims
$1,715
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,525 claims · $1.4M
Generic: 10,390 claims · $273K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 153 | $217K |
| Semaglutide | 102 | $160K |
| Dulaglutide | 80 | $133K |
| Empagliflozin | 42 | $80K |
| Mirabegron | 54 | $74K |
| Rivaroxaban | 42 | $67K |
| Insulin Degludec | 29 | $46K |
| Insulin Glargine/Lixisenatide | 32 | $43K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $38K |
| Insulin Aspart | 24 | $36K |
| Dapagliflozin Propanediol | 26 | $33K |
| Liraglutide | 13 | $31K |
| Sitagliptin Phosphate | 27 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 29 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 16 | $27K |
Prescribing Profile
Patient Profile
76
Avg Age
47%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About